Skip to Content

MN-REACH Seeks Med-Tech, Pharma Projects for Third Funding Cycle

Close up of different pills

An upcoming funding opportunity will help researchers who have developed cutting-edge medical technologies or pharmaceuticals bring these discoveries to market.

The University of Minnesota’s MN-REACH program, a National Institutes of Health’s Research Evaluation and Commercialization Hub, is accepting pre-proposals for its third funding cycle to help commercialize new med-tech and pharma inventions. MN-REACH aims to improve health care by fostering the development of breakthrough lab innovations — such as therapeutics, preventatives, diagnostics, devices and tools — into products that create health, economic and societal benefits.

Researchers can submit pre-proposals for MN-REACH Cycle 3 funding from Monday, Jan. 25 through Thursday, Feb. 11. The following informational sessions will review eligibility for the program and the application process:

  • U of M Duluth: Jan. 27, 11 a.m. to noon, 160 Life Sciences Building
  • East Bank: Jan. 28, mid-morning (to be determined), Moos Tower
  • St. Paul: Jan. 29, 1-2 p.m., 125 Coffey Hall

See the list of projects selected for MN-REACH funding during Cycle 1. Awardees of Cycle 2 grants will be announced in February.

Skills Development

In addition to providing funding opportunities to commercialize innovations, MN-REACH also provides educational opportunities for innovators that are developing their products and forming new partnerships both within and beyond the University.

Registration is now open for the free Medical Technology Commercialization Bootcamp. University faculty, staff and student health care researchers are invited to attend to learn about the commercialization process and the resources available to support bringing an innovation to market. The seminar will be held from 9 a.m. to 4 p.m. on Wednesday, Feb. 3 at the Mayo Building.

Contact mn-reach@umn.edu with questions.

Kevin Coss

Kevin Coss

Kevin is a writer with the Office of the Vice President for Research.

coss@umn.edu

Latest Blog Posts

Dr. Friedemann-Sanchez and Dr. Grieve sitting at a table together.

In 2018, two University of Minnesota researchers traveled to a United Nations council meeting to advocate for changes to address an epidemic of violence against women in Colombia.

Read More
Senior man speaks with a health care provider while looking at a digital display

Researchers aim to help train pharmacists and educate patients with the goal of improving medication outcomes for groups with higher rates of kidney failure.

Read More
Sironix banner in a laboratory space

Sironix Renewables uses a patented method to make nontoxic, sustainably-sourced surfactants that replace their counterparts made from petroleum.

Read More
Border crossing checkpoint from Mexico to US

As an expert witness on federal immigration court cases, Patrick McNamara provides insight into violence directly and indirectly related to drug cartels.

Read More